Symptom experience associated with immunosuppressive drugs after liver transplantation in adults: Possible relationship with medication non-compliance?

Clinical Transplantation

Volumn 22, Issue 6, 2008, Pages 700-709

  Drent, G ^a   Moons, P ^b   De Geest, S ^c   Kleibeuker, J H ^a   Haagsma, E B ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Liver transplantation; Medication non compliance; Non adherence; Side effect immuno suppression; Symptom experience

Indexed keywords

ANTIHYPERTENSIVE AGENT; AZATHIOPRINE; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CALCIUM CARBONATE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE; VITAMIN D;

ACNE; ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ANKLE EDEMA; ARTICLE; BACKACHE; COHORT ANALYSIS; COMBINATION CHEMOTHERAPY; CONCENTRATION LOSS; CONTROLLED STUDY; COUGHING; DEPRESSION; DIARRHEA; DRUG ERUPTION; DRUG FEVER; DRUG INDUCED HEADACHE; DYSMENORRHEA; FACIES; FATIGUE; FEMALE; FOLLOW UP; FRAGILE SKIN; GINGIVA HYPERPLASIA; GRAFT RECIPIENT; HAIR GROWTH; HUMAN; HYPERTENSION; IMPOTENCE; INCREASED APPETITE; INSOMNIA; LIBIDO DISORDER; LIVER CIRRHOSIS; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MODIFIED TRANSPLANT SYMPTOM OCCURRENCE AND SYMPTOM DISTRESS SCALE; MONOTHERAPY; MOOD DISORDER; MOON FACE; MUSCLE CRAMP; MUSCLE WEAKNESS; OSTEOPOROSIS; PAIN; PATIENT COMPLIANCE; PATIENT MONITORING; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RATING SCALE; SEX DIFFERENCE; SIDE EFFECT; SKIN BRUISING; SKIN DISEASE; STOMACH DISEASE; SYMPTOM; TREMOR; VISUAL IMPAIRMENT;

ADULT; AGED; AZATHIOPRINE; CROSS-SECTIONAL STUDIES; CYCLOSPORINE; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PREDNISOLONE; QUALITY OF LIFE; YOUNG ADULT;

EID: 56349098218     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2008.00864.x     Document Type: Article

References (39)

1. Karam VH, Gasquet I, Delvast V et al. Quality of life in adult survivors beyond 10years after liver, kidney and heart transplantation. Transplantation 2003: 76: 1699.
2. Forsberg A, Bädeman L, Möller A. Experiencing liver transplantation: A phenomenological approach. J Adv Nurs 2000: 32: 327.
3. Pless M, Zivkovic SA. Neurologic complications of transplantation. Neurologist 2002: 8: 107.
4. Rabkin JM, Corless CL, Rosen HR, Olyaei AJ. Immunosuppression impact on long-term cardiovascular complications after liver transplantation. Am J Surg 2002: 182: 595.
5. Lerut JP. Avoiding steroids in solid organ transplantation. Transpl Int 2003: 16: 213.
6. Encke J, Uhl W, Stremmel W, Saner P. Immunosuppression and modulation in liver transplantation. Nephrol Dial Transplant 2004: 19(Suppl. 4): 22.
7. De Geest S, Moons P. The patient's appraisal of side-effects: The blind spot in quality-of-life assessments in transplant recipients. Nephrol Dial Transplant 2000: 15: 457.
8. Lough M, Lindsey A, Shinn J, Stotts N. Life satisfaction following heart transplantation. J Heart Transplant 1985: 4: 446.
9. Lough ME, Lindsey AM, Shinn JA, Stotts NA. Impact of symptom frequency and symptom distress on self-reported quality of life in heart transplant recipients. Heart Lung 1987: 16: 193.
10. Moons P, De Geest S, Abraham I, Van Cleemput J, Vanhaecke J. Symptom experience associated with maintenance immunosuppression after heart transplantation: Patients'appraisal of side effects. Heart Lung 1998: 27: 315.
11. Moons P, Fairchild S, De Geest S. Patients'appraisal of side effects in quality of life assessments of immunosuppressive regimens. In: C ochat P, T raeger J, M erieux C, D erchaume E, eds. Immunosuppression Under Trial. London: Kluwer Academic Publishers, 1999: 69.
12. Texeira De Barros C, Cabrita J. Self-report of symptom frequency and symptom distress in kidney transplant recipients. Pharmacoepidemiol Drug Saf 1999: 8: 395.
13. Moons P, Vanrenterghem Y, van Hooff JP et al. Health-related quality of life and symptom experience in tacrolimus-based regimens after renal transplantation: A multicentre study. Transpl Int 2003: 16: 653.
14. Hugtenburg JG, Blom ATh G, Kisoensingh SU. Initial phase of chronic medication use; patients'reasons for discontinuation. Br J Clin Pharmacol 2005: 61: 352.
15. Rosenberger J, Geckova AM, van Dijk JP et al. Prevalence and characteristics of noncompliant behaviour and its risk factors in kidney transplant recipients. Transpl Int 2005: 18: 1072.
16. Acquadro C, Berzon R, Dubois D et al. Incorporating the patient's perspective into drug development and communication: An ad hoc task force report of the patient-reported outcomes (PRO) harmonization group meeting at the Food and Drug Administration, February 16, 2001. Value Health 2003: 6: 522.
17. Moons P, De Geest S, Versteven K et al. Psychometric properties of the Modified Transplant Symptom Occurrence and Symptom Distress Scale. J Nurs Meas 2001: 9: 115.
18. De Geest S, Abraham I, Moons P et al. Late acute rejection and subclinical noncompliance with cyclosporine therapy in heart transplant recipients. J Heart Lung Transplant 1998: 17: 854.
19. De Geest S, Borgermans L, Gemoets H et al. Incidence, determinants, and consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant recipients. Transplantation 1995: 59: 340.
20. Sundberg AK, Smith LD, Somerville KT, Cox R, Sherbotie JR. Conversion from cyclosporine to tacrolimus is preferred by pediatric renal transplant recipients: A focus on opinions and outcomes. Transplant Proc 2002: 34: 1951.
21. Artz MA, Boots JMM, Ligtenberg G et al. Conversion from cyclosporine to tacrolimus improves quality-of-life indices, renal graft function and cardiovascular risk profile. Am J Transplant 2004: 4: 937.
22. Cleemput I, Kesteloot K, Moons P et al. The construct and concurrent validity of the EQ-5D in renal transplant population. Value Health 2004: 7: 499.
23. Didlake RH, Dreyfus K, Kerman RH, Van Buren CT, Kahan BD. Patient noncompliance: A major cause of late graft failure in cyclosporine-treated renal transplants. Transplant Proc 1988: 10(Suppl. 3): 63.
24. Rovelli M, Palmeri D, Vossler E, Hull D, Schweizer R. Noncompliance in renal transplant recipients: Evaluation by socio-economic groups. Transplant Proc 1989: 21: 3979.
25. Rovelli M, Palmeri D, Vossler E, Bartus S, Hull D, Schweizer R. Noncompliance in organ transplant recipients. Transplant Proc 1989: 21: 833.
26. Schweizer RT, Rovelli M, Palmeri D, Vossler E, Hull D, Bartus S. Noncompliance in organ transplant recipients. Transplantation 1990: 49: 374.
27. Swanson AM, Palmeri D, Vossler ED, Bartus SA, Schweizer RT. Noncompliance in organ transplant recipients. Pharmacotherapy 1991: 11: 1735.
28. Mor E, Gonwa Th A, Husberg BS, Goldstein RM, Klintmalm GB. Late-onset acute rejection in orthotopic liver transplantation - associated risk factors and outcome. Transplantation 1992: 54: 821.
29. Sketris I, Grobler M, West M, Gerus S. Factors affecting adherence with cyclosporine in adult renal transplant recipients. Transplant Proc 1994: 26: 2538.
30. Sudan DL, Shaw BW Jr, Lagnas AN. Causes of late mortality in pediatric liver transplant recipients. Ann Surg 1998: 227: 289.
31. Rabkin JM, La Melena de V, Orloff SL, Corless CL, Rosen HR, Olyaei A. Late mortality after orthotopic liver transplantation. Am J Surg 2001: 181: 475.
32. Nevins THE, Kruse L, Skeans MA, Thomas W. The natural history of azathioprine adherence after renal transplantation. Kidney Int 2001: 60: 1565.
33. Avitzur Y, De Luca E, Cantos M et al. Health status ten years after pediatric liver transplantation-looking beyond the graft. Transplantation 2004: 78: 566.
34. Dobbels F, De Geest S, Van Cleemput J, Droogne W, Vanhaecke J. Effect of late medication noncompliance on outcome after heart transplantation: A 5-year follow-up. J Heart Lung Transplant 2004: 23: 1245.
35. Falkenstein K, Flynn L, Kirkpatrick B, Casa-Melley A, Dunn S. Noncompliance in children post-liver transplant. Who are the culprits? Pediatr Transplant 2004: 8: 233.
36. Vlaminck H, Maes B, Evers G et al. Prospective study on late consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant patients. Am J Transplant 2004: 4: 1509.
37. Drent G, Haagsma EB, De Geest S et al. Prevalence of prednisolone (non) compliance in adult liver transplant recipients. Transpl Int 2005: 18: 960.
38. Drent G, De Geest S, Haagsma EB. Prednisolone noncompliance and outcome in liver transplant recipients. Letter to the Editor. Transpl Int 2006: 19: 342.
39. Sermeus W, Delesie L. Ridit analysis on ordinal data. West J Nurs Res 1996: 18: 351.